Pedro M Folegatti

9PUBLICATIONS
41CO-AUTHORS
Innate immunityComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Infectious diseasesRadiation therapyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 06, 2026
Immunogenicity and safety of an inactivated split-virion influenza vaccine in individuals 6 months of age and older in India.

Pedro M Folegatti, Cynthia Tabar, Celine Petit

|Oct 07, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

Sue Ann Costa Clemens, Pedro M Folegatti, Katherine R W Emary

|Aug 28, 2021
Efficacy and Safety of a Modified Vaccinia Ankara-NP+M1 Vaccine Combined with QIV in People Aged 65 and Older: A Randomised Controlled Clinical Trial (INVICTUS).

Chris Butler, Chris Ellis, Pedro M Folegatti

|Jul 31, 2021
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.

Pedro M Folegatti, Kate Harrison, Lorena Preciado-Llanes

|May 22, 2021
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer

|May 07, 2021
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold

Pageof 2

Frequent Collaborators

7 joint publications

Katie J Ewer

6 joint publications

Adrian V S Hill

6 joint publications

Sarah Gilbert

5 joint publications

Daniel Jenkin